Status: Not yet recruiting
A Pilot Study of Ultra-High Dose Rate (ConformalFLASH®), for Reirradiation of Carcinoma of the Head and Neck
This pilot study is designed to evaluate the feasibility of delivering ultra-high dose-rate conformal proton therapy (ConformalFLASH) in participants requiring re-irradiation for head and neck cancer who are not amenable to surgical resection. ConformalFLASH treatment planning and delivery workflows are comparable to those of conventional Stereotactic Body Radiation Therapy (SBRT), a standard approach for re-irradiation in this population.
Participants needed: 10
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: IBA Proton Therapy, Inc.Updated: Jun 12, 2026Locations: 1
Eligibility criteria
Patients must sign an informed consent document that indicates they are aware of... [+7]
Receipt of prior head and neck radiotherapy within the prior 6 months [+9]